June 2011 Br J Cardiol 2011;18:133–7
Sudip Ghosh, Jude Smith, Jonathan Dexter, Colette Carroll-Hawkins, Noel O’Kelly
Introduction Hyponatraemia is a common electrolyte disorder among patients with heart failure (HF), nephrotic syndrome or cirrhosis.1-3 It is recognised as a predictor of adverse outcomes in hospitalised patients with these conditions,4-5 and its prognostic implications are commonly attributed to the severity of the underlying pathology. Patients admitted to hospital with decompensated heart failure have a poor prognosis, with in-hospital mortality rates approaching 10%.5-7 Hyponatraemia associated with decompensation results in added adverse outcomes resulting in high 30–90-day mortality and re-hospitalisation rates.5-9 These results have
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits